<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab2">
 <label>Table 2</label>
 <caption>
  <p>Demographic data of patients affected with different EVs in this study</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th colspan="6">Demographic data</th>
   </tr>
   <tr>
    <th>EV serotypes</th>
    <th>All</th>
    <th>CVA-6</th>
    <th>CVA-10</th>
    <th>CVA-16</th>
    <th>Others
     <sup>a</sup>
    </th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>Total number of patients</td>
    <td>
     <italic>N</italic> = 1220
    </td>
    <td>
     <italic>N</italic> = 364
    </td>
    <td>
     <italic>N</italic> = 305
    </td>
    <td>
     <italic>N</italic> = 397
    </td>
    <td>
     <italic>N</italic> = 154
    </td>
   </tr>
   <tr>
    <td colspan="6">Sex</td>
   </tr>
   <tr>
    <td> Male</td>
    <td>712(58.4%)</td>
    <td>223(18.3%)</td>
    <td>155 (12.7%)</td>
    <td>229 (18.8%)</td>
    <td>105(8.6%)</td>
   </tr>
   <tr>
    <td> Female</td>
    <td>508(41.6%)</td>
    <td>141(11.6%)</td>
    <td>150(12.3%)</td>
    <td>168 (13.8%)</td>
    <td>49(4.0%)</td>
   </tr>
   <tr>
    <td colspan="6">Age range (years)</td>
   </tr>
   <tr>
    <td>  &lt; 1</td>
    <td>164 (13.4%)</td>
    <td>56(4.6%)</td>
    <td>36(3.0%)</td>
    <td>39(3.2%)</td>
    <td>33(2.7%)</td>
   </tr>
   <tr>
    <td> 1–3</td>
    <td>656(53.8%)</td>
    <td>218(17.9%)</td>
    <td>173(14.2%)</td>
    <td>182 (14.9%)</td>
    <td>83(6.8%)</td>
   </tr>
   <tr>
    <td> 3–5</td>
    <td>332(27.2%)</td>
    <td>64(5.2%)</td>
    <td>87(7.1%)</td>
    <td>145(11.9%)</td>
    <td>36(3.0%)</td>
   </tr>
   <tr>
    <td>  &gt; 5</td>
    <td>68(5.6%)</td>
    <td>26(2.1%)</td>
    <td>9(0.7%)</td>
    <td>31(2.5%)</td>
    <td>2(0.2%)</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>
   <sup>a</sup> Note: Others included all EVs detected in this study except CVA-6, CVA-10, and CVA-16
  </p>
 </table-wrap-foot>
</table-wrap>
